FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1235.332

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113762.1.4.1235.332
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1235.332/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332
Version20230616
Statusactive
Date2023-06-16T01:00:56-04:00
NameHighRiskHPVTest_HD_Grouping
TitleHigh Risk HPV Test_HD_Grouping
Realmus
Authorityhl7
Descriptionb.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test.
Purpose(Clinical Focus: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Data Element Scope: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Inclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Exclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
loinc.orgLOINC Code System
sctSNOMED CT (all versions)
cptCurrent Procedural Terminology (CPT®)
HCPCSReleaseCodeSetsHealthcare Common Procedure Coding System (HCPCS) level II alphanumeric codes
ValueSet
2.16.840.1.113762.1.4.1235.328High Risk HPV Test_HD_CPT
2.16.840.1.113762.1.4.1235.329High Risk HPV Test_HD_HCPCS
2.16.840.1.113762.1.4.1235.330High Risk HPV Test_HD_LOINC
2.16.840.1.113762.1.4.1235.331High Risk HPV Test_HD_SNOMED

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1235.332",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "B.well Connected Health Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-07-02"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2023-06-16"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1235.332"
    }
  ],
  "version": "20230616",
  "name": "HighRiskHPVTest_HD_Grouping",
  "title": "High Risk HPV Test_HD_Grouping",
  "status": "active",
  "date": "2023-06-16T01:00:56-04:00",
  "publisher": "B.well Connected Health Steward",
  "description": "b.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Data Element Scope: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Inclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Exclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.328"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.330"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.331"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:74a78d61-1b95-4c6e-8e19-72b30aaf2ea4",
    "timestamp": "2025-05-23T20:23:15-04:00",
    "total": 24,
    "contains": [
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "21440-3",
        "display": "Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "30167-1",
        "display": "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "35904009",
        "display": "Human papillomavirus deoxyribonucleic acid detection (procedure)"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "38372-9",
        "display": "Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "441667007",
        "display": "Abnormal cervical Papanicolaou smear with human papillomavirus deoxyribonucleic acid detected (finding)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "448651000124104",
        "display": "Microscopic examination of cervical Papanicolaou smear and Human papillomavirus deoxyribonucleic acid detection cotesting (procedure)"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "59263-4",
        "display": "Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "59264-2",
        "display": "Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "59420-0",
        "display": "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "69002-4",
        "display": "Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "71431-1",
        "display": "Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "718591004",
        "display": "High risk human papillomavirus detected by cytology (finding)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "720005005",
        "display": "Human papillomavirus deoxyribonucleic acid detected, high risk on cervical specimen (finding)"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "75694-0",
        "display": "Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "77379-6",
        "display": "Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Cervix"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "77399-4",
        "display": "Human papilloma virus 16 DNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "77400-0",
        "display": "Human papilloma virus 18 DNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "82354-2",
        "display": "Human papilloma virus 16 and 18+45 E6+E7 mRNA [Identifier] in Cervix by NAA with probe detection"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "82456-5",
        "display": "Human papilloma virus 16 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "82675-0",
        "display": "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "87624",
        "display": "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "87625",
        "display": "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), types 16 and 18 only, includes type 45, if performed"
      },
      {
        "system": "http://loinc.org",
        "version": "2.80",
        "code": "95539-3",
        "display": "Human papilloma virus 31 DNA [Presence] in Cervix by NAA with probe detection"
      },
      {
        "system": "http://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets",
        "version": "2025",
        "code": "G0476",
        "display": "Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test"
      }
    ]
  }
}